Denali Capital Acquisition Corp. (DECAW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Mar 25Apr 9Nov 25Mar 2Mar 10Mar 13Mar 18Mar 23

Key dataMar 23, 2026

Open$0.04

From 52W high−67.67%

Volume11249.00

Market cap$79456.42

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataMar 23, 2026

Open

$0.04

From 52W high

−67.67%

Volume

11249.00

Market cap

$79456.42

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

44.4

MomentumView details →

1D Return

+1.31%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−0.0x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

0.00%

ROA (TTM)

0.00%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−100.00%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

−100.00%

MomentumView details →

1D Return

+1.31%

YTD Return

—

1Y Return

−34.01%

RSI (14)

44.4

vs 50D SMA

−17.44%

vs 200D SMA

−23.74%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

0.06x

Quick Ratio

0.06x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.08

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

0.00

Op. CF (TTM)

−6.05M

Latest newsMore news →

Semnur Pharmaceuticals announced a proposed $100 million private placement of newly issued common stock to iHolding Group LLP at $10.00 per share, subject to due diligence, definitive agreements, board and stockholder approvals, and regulatory approvals.76d ago

Similar companies

Keen Vision Acquisition Corporation WarrantKVACW byNordic Acquisition CorporationBYNOW Southern Cross Acquisition I Corp. WarrantsNCOOW Alchemy Investments Acquisition Corp 1ALCYW ClimateRockCLRCR FutureTech II Acquisition Corp.FTIIW Find similar companies →

Latest newsMore news →

Semnur Pharmaceuticals announced a proposed $100 million private placement of newly issued common stock to iHolding Group LLP at $10.00 per share, subject to due diligence, definitive agreements, board and stockholder approvals, and regulatory approvals.76d ago